Evidence map›Paper›PMID 42041374›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Genomic Epidemiology of ESBL and Non-ESBL-Producing

Hibatallah Sultan Al-Habsi, Zaaima Al Jabri, Amina Al-Jardani, Amira ElBaradei, Hafidha Al-Hattali, Faiza Syed, Zakariya Al Muharrmi, Wafa Al Alawi, Hatim Ali Eltahir, Meher Rizvi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hibatallah Sultan Al-HabsiCentral Laboratory of Animal Health, Muscat 100, Oman.ORCID 0009-0002-0438-1819
Zaaima Al JabriDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.ORCID 0000-0003-0000-3781
Amina Al-JardaniCentral Public Health Laboratories, Center for Disease Control and Prevention, Ministry of Health, Muscat 113, Oman.ORCID 0000-0001-6314-6849
Amira ElBaradeiDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.ORCID 0000-0001-6813-7896
Hafidha Al-HattaliDepartment of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.ORCID 0009-0005-8776-2327
Faiza SyedDASH to Protect Antibiotics, Muscat 111, Oman.ORCID 0000-0001-9887-4125
Zakariya Al MuharrmiDepartment of Microbiology and Immunology, University Medical City, Muscat 112, Oman.ORCID 0000-0002-6373-3354
Wafa Al AlawiCentral Analytical and Applied Research Unit, Sultan Qaboos University, Muscat 123, Oman.ORCID 0009-0007-7356-5255
Hatim Ali EltahirMinistry of Agriculture and Fisheries, Muscat 100, Oman.ORCID 0009-0002-3850-9884
Meher RizviDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.ORCID 0000-0002-8769-947X

Funding

Sultan Qaboos University (IG/MED/MICR/24/01)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMRanimalenvironmentESBLEscherichia colihumanOne Healthwhole genome sequencing

Identifiers

PMID42041374
PMCPMC13114006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.